Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245851988561
Publisher
SAGE Publications
Online
2019-11-04
DOI
10.1177/1352458519885613
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
- (2018) Christian Barro et al. BRAIN
- Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis
- (2018) Tanuja Chitnis et al. Annals of Clinical and Translational Neurology
- Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis
- (2017) I. Håkansson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
- (2017) Lenka Novakova et al. NEUROLOGY
- Neurofilament light chain level is a weak risk factor for the development of MS
- (2016) Georgina Arrambide et al. NEUROLOGY
- Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
- (2015) Ester Cantó et al. BRAIN
- Neurofilament dynamics and involvement in neurological disorders
- (2015) Benoit J. Gentil et al. CELL AND TISSUE RESEARCH
- Body fluid biomarkers for multiple sclerosis—the long road to clinical application
- (2015) Charlotte E. Teunissen et al. Nature Reviews Neurology
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis
- (2014) L. M. Villar et al. EUROPEAN JOURNAL OF NEUROLOGY
- Body fluid biomarkers in multiple sclerosis
- (2013) Manuel Comabella et al. LANCET NEUROLOGY
- A comparative study of CSF neurofilament light and heavy chain protein in MS
- (2013) Jens Kuhle et al. Multiple Sclerosis Journal
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
- (2013) Johanna Gaiottino et al. PLoS One
- Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta
- (2012) Robert A. Bermel et al. ANNALS OF NEUROLOGY
- Neurofilaments as biomarkers in multiple sclerosis
- (2012) Charlotte E Teunissen et al. Multiple Sclerosis Journal
- Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study
- (2010) RA Bermel et al. Multiple Sclerosis Journal
- Neurofilament light as a prognostic marker in multiple sclerosis
- (2010) Jonatan Salzer et al. Multiple Sclerosis Journal
- EFNS guidelines on disease-specific CSF investigations
- (2009) F. Deisenhammer et al. EUROPEAN JOURNAL OF NEUROLOGY
- Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
- (2009) C. E. Teunissen et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started